drugset / Trial / NCT04855435
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The Phase I trial is evaluating safety, tolerability, pharmacokinetics and preliminary efficacy of MBS8(1V270) in subjects with advanced solid tumours. The trial is designed to provide data for further clinical development of MBS8(1V270)
Timeline
- Start
- 2021-04-12
- Primary completion
- 2027-03
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MBS8(1V270) | Unknown | — | Intravenous |
| Background | Pembrolizumab | Monoclonal antibody | — | — |